StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
950140.KQ$9020.00-3.59%
Fair $9020.00+0.0%

950140.KQ

Englewood Lab, Inc.

Consumer Defensive / Household & Personal ProductsKOSDAQ

$9020.00

-340.00 (-3.59%)

Fairly Valued+0.0%Fair Value $9020.00Fund rank 35/100 · Data gapFallback financials|
SA 47/C
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 24% · confianza 25%

FCF escenarios

weak_data · normalized FCF $15.7B · quality 74.0/100

Data gap 35/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 67/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

47/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 950140.KQLocal privado en este navegador · Englewood Lab, Inc.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$179.2B

P/E

N/A

•

EV/EBITDA

4.0x

↓

ROE

15.1%

↑

Gross Margin

27.7%

↑

Debt/Equity

0.16

↓
52-Week Range$9020
$8900$16910

TradingView lightweight chart

950140.KQ price, volumen y niveles de valoración

Último $9,120Periodo +24.9%
Fair value: $9,020

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+12.7%

FCF CAGR

+43.2%

FCF margin

7.2%

FCF / Net income

0.63x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $216.79B · net income $24.81B · FCF $15.65B

2022-FY → 2025-FY

Gross margin

27.7%+10.6% pts

Operating margin

17.2%+10.7% pts

Net margin

11.4%+6.7% pts

FCF margin

7.2%+3.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$216.79B$216.79B$182.22B$206.78B$151.51B
Net Income$24.81B$24.81B$19.63B$20.74B$7.27B
EBITDA$42.14B$42.14B$31.77B$33.81B$13.68B
EPS——982.001044.00362.00
Gross Margin27.7%27.7%21.2%23.1%17.1%
Operating Margin17.2%17.2%10.3%14.0%6.5%
Net Margin11.4%11.4%10.8%10.0%4.8%
Balance Sheet
Debt/Equity0.160.160.210.110.27
Current Ratio3.663.66———
Cash Flow
Free Cash Flow$15.65B$15.65B$8.48B$18.04B$5.34B
Returns
ROE15.1%15.1%13.6%18.1%7.8%
Valuation
P/E——7.1513.8214.17
EV/EBITDA4.014.014.498.538.55
P/B1.091.090.982.491.11
Growth & Yield
Revenue Growth19.0%19.0%-11.9%36.5%—
EPS Growth——-5.9%188.4%—
Dividend Yield2.2%2.2%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -5.0%

Total return

-5.0%

Start / end P/E

n/dx → n/dx

EPS bridge

982.00 → n/d

Residual

-7.2%

EPS growthn/d
Multiple reratingn/d
Dividend+2.2%
Residual / FX / buybacks / cross-term-7.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.